Advertisement
Business
Subscribe to Business

The Lead

Johnson & Johnson Innovation Announces New Startup Campus

March 3, 2015 2:17 pm | by Andy Szal, Digital Reporter | News | Comments

The venture capital arm of the New Jersey consumer products giant officially unveiled its JLABS@South San Francisco campus Monday. The 30,000-square foot incubator will eventually house up to 50 startups.

Blueprint Medicines Announces $265M Strategic Collaboration with Alexion

March 3, 2015 1:48 pm | News | Comments

Blueprint Medicines has announced a strategic collaboration with Alexion to discover, develop...

Merz North America Appoints Vice President, Chief Compliance Officer

March 3, 2015 11:44 am | News | Comments

Merz North America has announced the appointment of Salisa Hauptmann as Vice President and Chief...

Sun Pharma to Buy GSK’s Opiates Business in Australia

March 3, 2015 9:05 am | News | Comments

The current GSK Opiates business including related manufacturing sites in Latrobe (Tasmania) and...

View Sample

FREE Email Newsletter

Nurse Who Survived Ebola Sues Dallas Hospital System

March 3, 2015 8:18 am | by JAMIE STENGLE, Associated Press | News | Comments

The Dallas hospital that treated the first patient to be diagnosed in the U.S. with Ebola lied to Congress when it said its staff was trained to handle the deadly virus, a nurse who contracted the disease contends in a lawsuit filed Monday.

New FDA Official Inherits Numerous Projects, Challenges

March 3, 2015 8:13 am | by MATTHEW PERRONE, Associated Press; MICHAEL FELBERBAUM, Associated Press | News | Comments

One of the nation's leading medical researchers joined the Food and Drug Administration on Monday, taking on the agency's No. 2 leadership job at a critical juncture for prescription drugs, medical devices and tobacco products.

AstraZeneca Completes Acquisition of Actavis’ Respiratory Products

March 3, 2015 8:05 am | News | Comments

AstraZeneca today announced that it has completed the transaction to acquire the rights to Actavis’ branded respiratory business in the US and Canada.

Advertisement

Pacira Pharma Slumps after FDA Ruling on Pain Drug

March 3, 2015 8:01 am | News | Comments

Shares of Pacira Pharmaceuticals tumbled Monday after the company said regulators refused to grant a new marketing approval for its post-surgical pain drug Exparel.

GSK Completes Transaction with Novartis

March 2, 2015 3:48 pm | News | Comments

Britain's GlaxoSmithKline PLC and Switzerland's Novartis AG have completed a three-part deal that will offer the British company's shareholders a 4 billion pound ($6.17 billion) windfall.

Firm Agrees to Refund to Settle Suit Over Weight-Loss Pills

March 2, 2015 8:48 am | News | Comments

A Salt Lake City-based company has agreed to pay refunds to consumers who purchased its weight-loss tablets to settle a class-action lawsuit that claimed its advertising slogan, "Eat All You Want & Still Lose Weight," was deceptive.

Teva Announces Sale of Sellersville, PA Facility

March 2, 2015 8:44 am | News | Comments

Teva Pharmaceutical Industries today announced that it has signed an agreement to sell its Sellersville, Pennsylvania facility to G&W Laboratories, Inc. This sale supports its plans to streamline operations by reducing excess manufacturing capacity and is part of the company’s previously announced cost reduction program.

Endo to Divest American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific

March 2, 2015 8:37 am | News | Comments

Endo International has entered into a definitive agreement with Boston Scientific, under which Boston Scientific will acquire Endo's American Medical Systems' (AMS) Men's and Prostate Health businesses for up to $1.65 billion, with $1.6 billion in cash payable at closing.

Advertisement

Cardinal Health to Acquire J&J’s Cordis for $1.944B

March 2, 2015 8:32 am | News | Comments

Cardinal Health today announced plans to acquire Johnson & Johnson's Cordis business, a global manufacturer of cardiology and endovascular devices, for $1.944 billion in cash, or approximately $1.594 billion, net of the present value of tax benefits.

PharMerica Corporation Announces Wholesale Drug Distribution Agreement with Cardinal Health

March 2, 2015 8:21 am | News | Comments

The new agreement will take effect on April 1, 2015 and extend through June 2018. As part of the agreement, Cardinal Health will assume responsibility for the sourcing and distribution of branded and generic pharmaceuticals for PharMerica.

PBOA Supports FDA SOS Act

March 2, 2015 8:14 am | News | Comments

Bipartisan Act would preserve FDA user fees from sequestration.

Report: Japan's Pharmaceutical Market to See 'Tepid' Growth

March 2, 2015 8:10 am | by Andy Szal, Digital Reporter | News | Comments

A recent report from research firm GlobalData predicted Japan will see a "tepid" recovery in its pharmaceutical market over the next several years. The London-based firm estimates Japan’s pharmaceutical market will climb from $72.8 billion in 2013 to $79.8 billion by 2020, a Compound Annual Growth Rate of 1.3 percent.

Federal Charges Filed Against New Jersey Drug Company

February 27, 2015 8:17 am | by Andy Szal, Digital Reporter | News | Comments

Federal prosecutors have indicted a New Jersey compounding pharmacy and top company officials on 37 charges, including wire fraud and violations of federal drug safety laws.

Advertisement

Ex-Sanofi CEO Joins PureTech's Board of Directors

February 27, 2015 8:09 am | News | Comments

PureTech, a science and technology R&D company focused  on identifying, inventing and commercializing disruptive products and technologies in the healthcare sector, has announced the appointment of Christopher Viehbacher, former CEO and Member of the Board of Directors of Sanofi, to its Board of Directors.

Court: J&J Must Pay South Carolina $136M for Deceptive Drug Marketing

February 27, 2015 8:00 am | by MEG KINNARD, Associated Press | News | Comments

South Carolina's high court says a Johnson & Johnson subsidiary should pay the state $136 million over deceptive drug marketing of an anti-psychotic drug.

Catalent Expands European Clinical Packaging Capabilities

February 26, 2015 3:01 pm | News | Comments

Catalent Pharma Solutions has announced several expanded capabilities within its European Clinical Supply Services network. The expansions have been implemented in response to increased customer demand for specialty clinical packaging, where the proportion of highly-potent or temperature-sensitive investigational medical products continues to increase.

Lawsuit Alleges Beneful Dog Food Killed Pets

February 26, 2015 8:39 am | Videos | Comments

Nestle Purina, the maker of Beneful, denies the claims in the lawsuit and says similar class-action lawsuits have been dismissed in the past.

Biota Pharmaceuticals to Acquire Anaconda Pharma

February 26, 2015 8:07 am | News | Comments

Biota Pharmaceuticals has entered into a definitive agreement to acquire Anaconda Pharma, a privately-held biotechnology company based in Paris, France. Anaconda Pharma's lead candidate is AP611074, a patented, direct-acting antiviral in development.

Administration: No Quick Fix if Court Kills Health Subsidies

February 25, 2015 8:33 am | by ALAN FRAM, Associated Press | News | Comments

President Barack Obama's health secretary told Congress Tuesday that she has no administrative actions available to fix the "massive damage to our health care system" that would result should the Supreme Court invalidate federal subsidies that help millions of Americans buy health care coverage.

Takeda Expands Pharma Operations in Singapore

February 25, 2015 8:14 am | News | Comments

Takeda Pharmaceutical Co., Japan's largest drug company, has expanded its Singapore operations by relocating its emerging markets business unit to the city-state from Zurich, executives said at an inauguration ceremony Wednesday.

Report: Vitamin Supplement Market Expected to Increase by 60 Percent by 2020

February 24, 2015 3:19 pm | by Andrew Szal, Editor, Pharmaceutical Processing | News | Comments

The analysis by New York-based Persistence Market Research predicted Vitamin D supplements would lead the growth in the industry over that span. The report expects increasing geriatric populations, particularly in Asia, to bolster demand for Vitamin D.

Turing Pharmaceuticals Launches - Management Team Announced

February 24, 2015 1:22 pm | News | Comments

Turing Pharmaceuticals AG announced its official launch today, along with news of three acquisitions for its commercial operations and development pipeline.  The company also introduced its senior management team.

Huntingdon Life Sciences and Harlan Laboratories to Operate Under New Brand and Name

February 24, 2015 11:11 am | News | Comments

Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the two companies will be rebranded to reflect the new integrated management structure that has been put in place and the broader product and service offerings of the combined organizations.

NY AG Expands Herbal Supplements Investigation

February 24, 2015 8:25 am | by MARY ESCH, Associated Press | News | Comments

Three weeks after ordering four major retailers to pull store-brand herbal supplements off their shelves following DNA tests that found little or none of the listed herbs, New York's attorney general is targeting manufacturers of the popular products.

Shire Acquires Meritage Pharma

February 24, 2015 8:08 am | News | Comments

Shire has acquired Meritage, a privately-held company, for an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory milestones.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading